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AWARDS ABSTRACT 
NON-INVASIVE METHOD AND APPARATUS FOR MONITORING 
INTRACRANIAL PRESSURE AND PRESSURE VOLUME INDEX IN HUMANS 
The present invention relates to the monitoring of intracranial pressure and 
pressure volume index in human patients in a non-invasive manner. 
Referring to FIGS. 1 A-1 6, the pressure volume index, a constant for any given 
patient, is determined by successive measurements of the patient's blood flow 
through a jugular vein. The blood flow is measured by a blood flow meter in contact 
with the patients neck which displays its results on an electronic display device. The 
first measurement is obtained while the patient is lying in the supine position, and a 
second measurement is obtained after tilting the patient's feet upward. By comparing 
the pressure and volume differences obtained as a result of the two measurements, 
an accurate value for the pressure volume index is obtained. 
Referring to FIG. 3, once the pressure volume index for a given patient has 
been obtained, the intracranial pressure can be continuously monitored with an 
ultrasonic transducer to measure the volume of the patient's cranium in conjunction 
with a blood f low monitor attached to the patient's neck to  measure the blood flow 
through a jugular vein. 
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NON-INVASlVE METHOD FOR MEASURING AND MONITORING
INTRACRANIAL PRESSURE AND PRESSURE VOLUME INDEX
5
10
Origin nf the invention
The invention described herein was made in the performance of
work done by employees of the U.S. Government and may be
manufactured and used by or for the government for governmental
purposes without the payment of any royalties thereon or therefor.
Bankground of the invention
Field of the invention
15 This invention relates in general to measuring/monitoring of
intracranial pressure and pressure volume index in human patients, and
more specifically to a non-invasive method for monitoring intracranial
pressure and changes in intracranial pressure.
20 Description of the related art
Monitoring of intracranial pressure and pressure volume index is of
significant diagnostic and post-operative importance for patients with
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cranial injuries, pathologies, or other conditions, that may affect the
pressure of the subarachnoidal fluid around the brain, and for patients
who have undergone brain surgery.
Intracranial pressure is regularly measured and monitored by
5 means of a pressure sensor inserted through the skull into the brain.
Usually a hole is drilled in the skull, and a catheter with a pressure sensor
is inserted into the brain fluid. To obtain a pressure volume index, the
change in intracranial pressure is monitored after a known bolus of saline
solution is inserted into the cerebrospinal fluid, or after a saline solution
10 is inserted at a known rate. This known procedure, while simple and
accurate, is not suitable for long term monitoring, because an open
wound must be maintained in the skull for the catheter with the pressure
sensor. Antibiotics are only partially effective in treating cranial
infections, so the pressure sensor can only be left in situ for two weeks
15 or less.
Long term monitoring of intracranial pressure, without the need for
maintaining an open wound in the skull, is possible if a pressure sensor
with a transmitter is implanted into the brain. The intracranial pressure is
thereafter monitored by means of a receiver located outside the skull.
20 Such a solution however, is unattractive because of risks involved in
implanting anything in the brain, and because of the problems of
providing power to an implanted transmitter. One such remote pressure
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sensor is described in U.S. Patent 4,124,023 to Fleischmann et al.
However, this device uses nuclear material as an energy source, making
it poorly suited for implantation into a human brain.
Other methods, claiming to be non-invasive methods suitable for
5 monitoring of intracranial pressure, are based on the measurement of
some quantity that depends on intracranial pressure, but which does not
have a fixed relationship to intracranial pressure.
One such method is described in U.S. Patent 4,204,547 to
Allecca. tMlocca occludes the blood flow in a jugular vein for a few
10 seconds, and measures the resulting rate of change of blood flow within
the jugular vein upstream of the occlusion as an indicator of the
intracranial pressure.
Another such method, proposed in U.S. Patent 4,564,022 to
Rosenfeld et al., directs a sensory stimulus towards the patient, e.g. a
15 flash of light into the eyes, and measures the latency of a resulting
negative-going wave of electrical brain activity as an indicator of
intracranial pressure.
These known indirect methods may be used, under very restricted
conditions, as possible indicators of variations of the intracranial pressure
20 in a patient. However, absolute values for the intracranial pressure
cannot be obtained directly as there is no predetermined fixed ratio
between the observed signals, obtained by these known non-invasive
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monitoring methods, and the absolute value of the intracranial pressure.
Such calibration is possible by inserting a pressure sensor into the brain
of the patient being monitored, however, this is a traumatic and
undesirable procedure.
_ummary of the Invention
Accordingly, it is the object of the present invention to provide a
non-invasive method for measurement of absolute values of intracranial
10 pressure and pressure volume index in a human patient.
It is another object of the present invention to provide a non-
invasive method for long term monitoring of both intracranial pressure
and the pressure volume index in a human patient.
It is a further object of the present invention to provide a non-
15 invasive method for calibrating indirect measurements of intracranial
pressure to obtain absolute values for intracranial pressure.
It is a still further object of this invention to provide a means to
monitor changes in intracranial pressure in a human patient.
These and other objects of the invention are achieved by a method
20 for non-invasive measurement of intracranial pressure and pressure
volume index, which comprises the steps of: providing a non-invasive
measuring device responsive to intracranial pressure, calibrating said
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measuring device by introducing known changes in intracranial pressure
and recording the pressure changes by the measuring device, inducing
known changes in the volume of the cerebrospinal fluid while measuring
the corresponding changes in intracranial pressure by means of said
calibrated measuring device, obtaining two sets of corresponding values
for change in volume (AV) and change in intracranial pressure (Ap),
entering each of the two sets of values for AV and AP into equation
Av
PVI
Ap . PO (i0 -I)
io
to form a set of two equations with Po and PVI unknown, and
solving said set of two equations for PVI and Po to obtain accurate values
for the pressure volume index PVl and the intracranial pressure Po for the
patient.
15
20
Brief Description of the Drawings
These and other objects of the present invention will be
understood from the description herein, with reference to the
accompanying drawings, in which:
FIG. 1A is a side view of a patient with sensing devices attached
to forehead and neck lying in supine position on a horizontal hospital bed;
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FIG. 1B is a side view of a patient with sensing devices attached
to forehead and neck lying in supine position on a tilted hospital bed;
FIG. 2 is a perspective view of a seated patient with a sensing
device attached to the forehead and fitted with a pressurized skull cap;
FIG. 3 is a perspective view of a patient with a sensing device
attached to the forehead lying on the side;
FIG. 4 is a block diagram of a preferred measuring device for use
with the invention.
10 Detailed Description of a Preferred Embodiment
The human brain and the spinal cord are immersed in a fluid called
the cerebrospinal fluid. The cerebrospinal fluid (csf) is continuously
generated and reabsorbed by the body. The csf is contained in a
15 membrane covering the inside of the skull and the spinal cord, having a
sack at the sacrum. The brain and the membrane containing the csf also
contain blood vessels, which are in direct communication with the csf
and add to the total volume of the cerebrospinal system. The blood
volume varies rhythmically with the heart beat, causing corresponding
20 oscillations in the intracranial pressure (ICP). An accurate regulating
process in the brain normally controls the generation process, the
reabsorption process and the blood volume in the brain to maintain a
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constant ICP average value of about 40 mmH..
process can be disturbed, e.g. by tumors in the brain, or by trauma to
the brain, causing the ICP change. As little as 10 mmH= increase above
average value in the ICP may cause insidious damage to the brain.
When the ICP varies, the total volume of the csf also varies. As
an example a relationship between volume and ICP is expressed by
equation (1) for the cerebrospinal system for small values of (V-Vo).
v-v o
P.Poxl 0 PVI
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However, the regulating
(1)
10
15
where: P
V
Po
V o =
PVl
= peak ICP
= csf volume associated with P
= Steady state reference pressure for ICP
Steady state reference volume of csf
corresponding to Po
= Pressure-Volume Index
2O
PVl is a constant that depends on pathological conditions of a
given patient and varies from patient to patient, such that no fixed or
predetermined value for PVl can be used in equation (1). An accurate
value for PVl can, however, be calculated from known values for
changes in ICP (AP) and volume (AV) as follows:
Subtracting Po from each side of equation (1) gives equation (2):
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(2)
5
where AV = V - V o = small variation in volume from V o
AP = P - Po = small variation in pressure from Po
If two pairs of AV and AP are measured, equations (3a) and (3b)
are obtained:
A pi.Po (10 Avl/PVI-I)
(3a)
AP2-P 0 (I oAV2/ PVI-I )
(3b)
10
15
Equations (3a) and (3b) are a set of two equations with only two
unknown variables, PVl and Po, so PVl and Po can be calculated by
solving the simultaneous equations (3a) and (3b) by known methods.
Examples of methods for solving this set of equations are given below.
By taking the ratio of equations (3a) and (3b), equation (4) is
obtained:
AP 1 IoAVJPVI_I
AP 2 IoAV2/PVI_I
(4)
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A quite accurate value for PVl is obtained by inserting into
equation (4) data from the measurement of two pairs of corresponding
values for AV and AP and fitting a computer generated algorithm of
equation (4) to the data by varying PVl, or by using the "SOLVE"
5 function in modern scientific calculators.
An approximate, but quite accurate, value for PVl may also be
obtained by expanding the exponential functions in the numerator and
the denominator of the right hand side of equation (4) in a truncated
power series, collecting terms, and solving the resulting equation for PVI.
10 If the first three terms in the power series is kept, equation (5) for PVl is
obtained:
PVI -
API _ 2
__ (AV2)2 (AVl)
AP 2
0. 868 [AV I- APIAvo]
AP2
(5)
If the first four terms in the power series is kept, the more
15 accurate, but still approximate, equation (6) for PVl is obtained:
A
PVI - --
B
(6a)
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Where:
AP 1
A - 4.61[_p-_2 (AV2)3-(AV1)3]
(6b)
and:
B- 3[(z_v 1)2 AP1
AP 2---(AV2)2],[2 Ap 2 (AV1)3(AV2)'24- AP2 (AV2) 3 (AV1)
1
AP1 • AP1 4] -2
-18 AP2 (AVl)2-(AV2)2-15 (_2) (AV 2) 4-15 (AV 1)
(6c)
Once PVI is obtained, Pocan be calculated from either of equations
(3a) or (3b) by inserting the correct value for PVI.
Another way to calculate PVI from a single measured pair of Z_P
10 and AV when PVI has been determined may also be obtained by taking
the derivative of equation (1) to get equation (7)"
AV
dP P0 (7)
i0 PVI
dV 0. 434 (PVI)
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For small variations in P and V, dP and dV can be replaced by Ap
and AV, respectively, and the resulting equation solved to get an
approximate, but quite accurate equation (8) for Po:
-AV
P0 " 0.434 (PVI) API0 PVI (8)
Av
5 Measurements of AP and AV can be obtained by non-invasive
methods. Two preferred methods, but by no means the only methods, to
measure AP and AV for the determination of intracranial pressure and
pressure-volume index will be described below.
It is commonly assumed that the skull of an adult is so rigid that
10 the skull volume is constant. It is therefore assumed that changes in csf
volume (AV) involve mainly compression of the spongy brain tissue.
Comprehensive tests have shown that this assumption is incorrect. The
skulls of adults actually expand and contract like balloons with changes
in ICP, and this expansion and contraction of the skull accounts for
15 almost all of the volume changes in the csf caused by variations in the
ICP.
Any measurement system or device sufficiently sensitive to
respond to appropriate anatomical configuration changes caused by
pressure changes can accordingly be used to measure changes in ICP. A
20 preferred device for measuring small variations in skull size in response to
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variations in ICP is the constant frequency pulsed phase-locked-loop
(CFPPLL) ultrasonic measurement device described by U.S. Patent
5,214,955 issued to Yost and Cantrell, and also described in a paper
entitled "Constant frequency pulsed phase-locked-loop instrument for
5 measurement of ultrasonic velocity" by Yost, Cantrell and Kushnick,
published in Rev. Sci. Instrum. 62 (10) October 1991. The CFPPLL
measurement device applied to measuring or monitoring intracranial
pressure will be described below with reference to FIG. 4.
The signal from the ultrasonic CFPPLL device depends on the
10 diameter of the cranium and is not a direct measure of the intracranial
pressure ICP. This is true for all measurement devices based on
mechanical deformation of the skull or related structures, as well as all
other known non-invasive measurement devices responsive to intra-
cranial pressure variations. The signal from such non-invasive
15 measurement devices thus can not be used for measurements or
monitoring of absolute ICP variations unless a calibration as will be
described herein has first been performed.
2O
A. Methods to measure AP.
1. Tilt angle method.
FIGS. 1A and 1B show a patient 10 lying supine on a hospital bed
40. An ultrasonic transducer 20 mounted on the front of the skull above
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the nose and approximately 1 cm below the hairline is connected via a
cable 22 to an electronic apparatus 30. The measuring device 20, 30
provides an output proportional to changes in the travel time of an
ultrasonic toneburst emitted by the transducer 20 and reflected back to
5 the transducer 20 from the opposite side of the skull 12 or other
appropriate landmark.
In FIG. 1A the bed 40 is horizontal, and in FIG. 1B the bed 40 is
tilted by an angle (p from the horizontal 26, such that the patient's legs
19 are higher than the head 12. The cerebrospinal fluid is contained in
i0 membranes extending from the inside of the top of the skull 12 to the
sacrum, which lies approximately at "S" in FIGS. 1A and lB. When the
bed 40 is tilted as shown, the intracranial pressure will increase. If the
distance from the center of the skull 12 to the sacrum is L, as indicated
in FIGS. 1A and 1B, the increase in pressure will be as given in equation
iS (9):
Ap -pgLsin@ (9)
20
where:
Ap = Pressure change
p = Mass density of the spinal fluid
g = Gravitational constant
L = Distance
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q) = Tilt angle for patient
By using various tilt angles @, the various changes in intracranial
pressure (ICP) can be calculated from equation (9). These calculated
changes in ICP can be used to calibrate the output from the measuring
device 30, or any other appropriate measuring device sufficiently
sensitive to respond to appropriate anatomical configuration changes
caused by changes in intracranial pressure.
2. Pressurized skull cap method.
10 FIG. 2 illustrates another method of calibration, which uses a
helmet 40 containing an inflatable skull cap 45, in which a known
pressure is applied to the cranial vault 12 by means of a hose 57, a
pump 50, a valve 55, and a manometer 60. Calibration is accomplished
by correlating the output of a measuring device with a transducer 20
15 mounted on the front of the skull 12 with the applied pressure in the
skull cap 45. The accuracy of this method depends on the refinements
of the design of the skull cap 45 and may differ from the accuracy of the
tilt-angle method outlined above.
20 B. Methods to vary and measure AV:
1. Bolus Injection method.
FIG. 3 shows a patient 10, whose cerebrospinal axis is in the
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supine position, but where the patient is rotated onto the patient's side.
The patient has an ultrasonic transducer 20 placed against the skull
directly above the nose and approximately one centimeter below the hair
line. This transducer 20 is connected via cable 22 to an electronic
5 apparatus 30 for measurement of small variations in the diameter of the
skull 12.
Between appropriate vertebrae, or at an other appropriate access
point, a measured bolus of saline or other appropriate solution is injected
by a syringe 70 into the cerebrospinal system. Let the volume of a first
10 injection be AV 1. By assuming that the injection of this bolus is given at
the clinically recommended and appropriate injection rate, it will give rise
to a peak change in intracranial pressure API. This pressure change AP 1
is measured by readings from the measuring device 20, 30, which
previously has been calibrated by the tilt angle method or the pressurized
15 skull cap method, and is recorded along with the corresponding bolus
injection volume AV 1.
After allowing time for the intracranial pressure ICP to equilibrate
to its steady state value following the first bolus injection, a second bolus
injection of volume AV 2 is given, and the resulting peak change in
20 intracranial pressure AP 2 is measured.
The two measured pairs of values of AV and AP are then inserted
into equations (3a) and (3b), and the patient's pressure-volume index PVl
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and the intra-cranial pressure Po is calculated by solving the two
simultaneous equations by one of the methods described above in
connection with equations (4) - (8).
5 2. Blood Flow Method:
Another method for measurement of AV is based on measurement
of changes in blood flow to the brain, as indicated in FIG. 1A.
A patient 10 resting in supine position on a horizontal hospital bed
40 has an ultrasonic transducer 20 placed against the front of the skull
10 12. The transducer 20 is connected via a cable 22 to an electronic
apparatus 30 for accurate measurement of small variations in the
diameter of the skull 12. The measuring device 20, 30 has previously
been calibrated by the tilt angle method or the pressurized skull cap
method described above to provide accurate readings of variations in the
15 intracranial pressure.
The patient 10 also has an ultrasonic blood flow transducer 25
mounted on the neck. The blood flow transducer 25 is connected via a
cable 27 to an electronic apparatus 35. The blood flow transducer 25
with associated electronics 35 is arranged to measure the blood flow in
20 the patient's jugular vein. The diameter of the jugular vein can be
determined by using an ultrasonic A-scan instrument. By using the
determined vein diameter together with the velocity profile from the
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blood flow meter, an instantaneous blood volume change can be
determined. Devices for measurement of blood flow and blood vessel
diameter are well known in the art, and will not be discussed in detail
herein.
5 Theoretically, net blood flow into or out of the brain would require
measurement of the blood flow in all veins as well as in all arteries that
service blood flow out of and into the cerebral system. In most cases it
is, however, possible to model the total blood flow from measurement of
blood flow in one vein. With this in mind, we measure (1) the diameter
10 of the vein, and (2) the velocity profile of the venous flow. We calculate
a blood volume flow rate in a manner known to those skilled in the art.
The change in the blood volume flow rate is measured at a
temporary occlusion of an artery or a vein. One can then calculate a first
change in blood volume AV 1, which is recorded together with the
15 corresponding change AP1 in ICP, as measured by the previously
calibrated pressure responsive measuring device 20, 30.
A second pair of data, AV 2 and AP 2, is obtained by occluding a
different vein or artery. The two pairs of data are inserted into equations
(3a) and (3b), and PVl and Po are then calculated by solving the two
20 equations, e.g. as described above with reference to equations (4)-(8).
After the patient's pressure-volume index PVl and steady state
intracranial pressure Po has been determined, the calibrated measuring
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device 20, 30, or any other calibrated measurement device responsive to
changes in intracranial pressure, can be used to monitor changes in ICP
directly and continuously.
FIG. 4 is a block diagram for a Constant Frequency Pulsed Phase-
5 Locked-Loop (CFPPLL) ultrasonic measurement device, which is a
preferred measurement device for use as part of the invention.
The CFPPLL measurement system uses properties of an ultrasonic
wave propagating along a path defined by the ultrasonic beam and bound
by the skull-meninges-dura complex, or appropriate substructures within
10 this complex, and the measured change in the phase of the propagating
ultrasonic wave due to the change in the wave propagation path length
accompanying a change in ICP is used as a measure of variations in ICP.
The CFPPLL measuring device is preferred because it provides very high
sensitivity and excellent repeatability and long term stability.
15 The CFPPLL measuring device includes an ultrasonic transducer
20, which is shown mounted on the front of the skull 12 of a patient
under monitoring. The transducer 20 is via cable 22 supplied with
variable width acoustic tonebursts from an electronic apparatus 30,
which includes a constant frequency synthesizer 100 followed by a
20 power splitter 110, a gate 115, which determines the width of the
acoustic toneburst, a power amplifier 120, and a coupling/decoupling
network 125.
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Acoustic signals reflected from the far side of the skull 12 is
received by the transducer 20 and channelled via the cable 22, the
coupling/decoupling network 125, and a preamplifier 130 to a first input
(1) of a phase detector 140. A second input (2) of the phase detector
5 140 receives a second signal from the synthesizer 100 via a power
splitter 110, a buffer 112, a voltage controlled phase shift network 170,
a calibrated line stretcher 175, and another buffer 172.
The output signal from the phase detector 140 is fed via a sample-
and-hold circuit 150 to an integrator 155, and from the integrator 155
10 via a normally closed phase shift control switch 168 to an adder circuit
160, which also receives a phase set point voltage from a phase set
point potentiometer 165. The output from the adder circuit 160 is fed as
a control voltage to input 180 of the phase shift network 170, and also
to a digital voltmeter 200 used as readout for the measuring device. The
15 digital voltmeter includes an IEEE interface connection 210 for external
data storage and processing.
A timing control unit 190 provides all sync and control signals for
the gate 115, the coupling/decoupling network 125, and the sample-and-
hold circuit 150. The coupling/decoupling network 125 protects the
20 preamplifier 130 from overload by decoupling the preamplifier 130 from
the transducer 20 when large voltage drive signals are coupled to the
transducer 20, and it improves system sensitivity by decoupling the
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output of the low-impedance drive amplifier 120 from the transducer 20
when a reflected signal is received by the transducer 20.
The apparatus 30 also provides outputs for supervision and setup,
including transducer output 133, phase comparison output 143, control
5 point monitor output 153, and sync signal output 193.
The function of the CFPPLL system outlined above is best
understood by considering that a constant frequency signal from an
oscillator 100 is split into two signal paths, 1 and 2, and that phase
differences between the two signal paths are measured.
10 Along path 1, which is a measurement path, an acoustic signal
generated in transducer 20 traverses the material enclosed by the skull
12 of the patient. The acoustic toneburst travels through the material
enclosed by the skull 12, is reflected at the far end of the skull 12, and
impinges on the transducer 20 as an echo of the original pulse. Any
15 changes in the propagation conditions, such as path length changes,
produce associated phase changes in path 1. These phase changes are
the information sought in measurement.
Path 2, which is a reference path, includes a voltage controlled
phase shift network 170, whose output is used for phase comparison
20 with the signal from the measurement path (1). The phase detector 140
detects the relative phase difference between the signals in the two
paths, and generates an output signal proportional to the cosine of the
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phase difference. The control voltage to the voltage controlled phase
shift network 170 is automatically changed until the output voltage of
the phase detector 140 is zero, which occurs when the two signals are in
quadrature.
5 The input to the voltage controlled phase shift network 170 comes
through a buffer 112 from the power splitter 110. The buffer 112
provides matching of the electrical input impedance to that of the phase
shift network 170. The phase shift is controlled by a dc voltage applied
to a control input 180 of the voltage controlled phase shift network 170.
10 The output of the voltage controlled phase shift network 170 passes
through a calibrated line stretcher 175, used for calibration of the
system, and a buffer 172 to the phase detector 140. During data
collection the setting of the calibrated line stretcher 175 is not changed.
Phase comparison of the two paths is performed by the phase
15 detector 140, which is a product detector combined with a low pass
filter. The phase detector 140 output voltage can be written as one-half
the product of the input voltage amplitudes times the cosine of the phase
difference between the two signals. The output of the phase detector
140 is passed both to the sample-and-hold circuit 150, which selects the
20 desired portion of the phase signal, and to an output port 143 through a
buffer 142 for observation on an oscilloscope (not shown). The portion
of the phase signal chosen for measurement is selected by an adjustable
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timing pulse to the sample and hold circuit 150, whose output is passed
to an integrator 155.
The loop control circuit, which is made up of the sample-and-hold
150, the integrator 155, the phase set point potentiometer 165, and the
5 adder 160, provides the control voltage 180 for the voltage controlled
phase shift network 170. The control voltage 180 is a sum of two
contributions, one coming from the integrator 155, and the other coming
from the phase set point potentiometer 165. The phase set point
potentiometer 165 sets the nominal phase shift about which the system
10 operates. The integrator 155 provides a voltage derived from the phase
detector 140. When the phase detector 140 output reaches null, the
integrator 155 output voltage stabilizes to a constant voltage, and
quadrature between paths 1 and 2 are established. The phase shift
control switch 168 is closed in the "locked" state when the system is
15 taking a measurement. For setup, it is moved to its open "unlocked"
state, so that the voltage controlled phase shift network 170 is under
manual control by the phase set point potentiometer 165.
The timing control unit 190 forms all of the necessary timing
signals needed by various sections for the measurement application. All
20 timing signals are referenced to the repetition rate, which is determined
by counting down from the synthesizer 100. The sync output marks the
beginning of the formation of a toneburst and is used for measurement
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setup and display. An adjustable width of the toneburst is also provided.
Signals to the coupling/decoupling network 125 and the sample-and-hold
circuit 150, used to measure the phase of the selected portion of the
received ultrasonic wave, are controlled by this unit. Timing sequences
5 are adjusted with the aid of an oscilloscope.
Adjustments for measurements are made in the following way:
With the outputs properly connected to an oscilloscope and the
phase shift control switch 168 in the open ("unlocked") position, the
received tonebursts and the phase comparison voltages are displayed.
10 The frequency of the synthesizer 100 is adjusted so that the amplitudes
of the reflected toneburst echoes at output 133 are far out of the noise,
and the phase comparison output voltage at output 143 is relatively "flat
topped" and stable at that portion of the tone burst echo chosen for
measurement. The phase set point potentiometer 165 is adjusted until
15 the phase comparison voltage 180 corresponding to the desired tone
burst is approximately 0 V. The control point is adjusted so that the
phase signal is sampled well into its latter half. Because of a time delay
in the low-pass filter in the phase detector 140 the phase signal is not
precisely synchronized with the tonebursts. The phase shift control
20 switch 168 is then placed in its closed ("locked") position for data taking.
A calibration procedure that uses a line stretcher 175 in the
reference path (2) permits the conversion of the change in control
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voltage, monitored by the voltmeter 200, to a change in phase shift
between the two paths. Calibration of the voltage controlled phase shift
network 170 in a CFPPLL system is normally accomplished by adjusting
the calibrated line stretcher 175 to introduce a known phase shift into
5 the calibration path while the system is locked in data taking mode. This
results in a change in the phase shift control voltage 180 to the voltage
controlled phase shift network 170. The change in phase shift control
voltage 180 is recorded, and a change of output voltage for a known
phase shift is thus determined. This result is used to calculate changes
10 to the measured phase shifts and, is particularly important information to
have in setups requiring measurements of small phase shifts of a few
hundred microradians.
When the CFPPLL system is used for measuring and/or monitoring
intracranial pressure ICP and pressure-volume index PVl according to the
15 present invention, such absolute calibration of output versus phase angle
is not required, but instead the change in output versus change in ICP is
calibrated by the tilt angle method or the pressurized skull cap method as
described above.
The method described above for non-invasive determination of PVl
20 and ICP according to a preferred embodiment of the invention is not only
useful for direct monitoring of ICP, but also for calibration of other
measuring devices using indirect methods for non-invasive monitoring of
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ICP. Such non-invasive measuring devices include, but are not limited to,
calipers, head bands, or other devices and measurement systems
possessing the sensitivity and accuracy to allow proper calibration, for
example, by using the measurement systems to monitor any dimensional
5 changes in the skull or other connected systems, such as the eyeball,
inner ear, or anatomical landmarks within or adjacent to the cranial cavity
and/or the spine or attached or adjacent structures, or configurational
changes of the spine or any other structures responding to increases in
intracranial pressure. The invention makes it possible to calibrate such
10 devices so accurate continuous recordings of absolute values of ICP can
be obtained without the need for invasive procedures.
Numerous modifications and adaptations of the present invention
will be apparent to those skilled in the art. Thus, the following claims
and their equivalents are intended to cover all such modifications and
15 adaptations which fall within the true spirit and scope of the present
invention.
What is claimed is:
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NON-INVASIVE METHOD FORMEASURING AND MONITORING
INTRACRANIAL PRESSUREAND PRESSUREVOLUME INDEX
5
Abstract of the DisclosurR
Non-invasive measuring devices responsive to changes in a
patient's intracranial pressure (ICP) can be accurately calibrated for
monitoring purposes by providing known changes in ICP by non-invasive
methods, such as placing the patient on a tilting bed and calculating a
10 change in ICP from the tilt angle and the length of the patient's
cerebrospinal column, or by placing a pressurized skull cap on the patient
and measuring the inflation pressure. Absolute values for the patient's
pressure-volume index (PVI) and the steady state ICP can then be
determined by inducing two known changes in the volume of
15 cerebrospinal fluid while recording the corresponding changes in ICP by
means of the calibrated measuring device. The two pairs of data for
pressure change and volume change are entered into an equation
developed from an equation describing the relationship between ICP and
cerebrospinal fluid volume. PVI and steady state ICP are then determined
20 by solving the equation. Methods for inducing known changes in
cerebrospinal fluid volume are described.
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